John Pablo
Impact in
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 14
- Neuroscience and Neuropharmacology Research 5
- Nuclear Receptors and Signaling 2
-
- Receptor Mechanisms and Signaling 5
- Co-authors
- Deborah C. Mash (26 shared papers)William Lee Hearn (6 shared papers)Neil Hammerschlag (2 shared papers)Yujing Qin (5 shared papers)Sandra Anne Banack (2 shared papers)Larry E. Brand (1 shared paper)Sari Izenwasser (2 shared papers)Terence E. Johnson (1 shared paper)
- Journals
- Neuroreport (2 papers)Journal of Neurochemistry (2 papers)Annals of the New York Academy of Sciences (2 papers)Gene Expression (1 paper)Marine Drugs (1 paper)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
John Pablo
26 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Cellular and Molecular Neuroscience 781
- Neurology 375
- Toxicology 81
- Biochemistry 163
- Neurology 129
Countries citing papers authored by John Pablo
This map shows the geographic impact of John Pablo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pablo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pablo more than expected).
Fields of papers citing papers by John Pablo
This network shows the impact of papers produced by John Pablo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pablo. The network helps show where John Pablo may publish in the future.
Co-authors
The 25 scholars most cited alongside John Pablo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 268 | |
| 2 | 2010 | 202 | |
| 3 | 2002 | 121 | |
| 4 | 1992 | 113 | |
| 5 | 2000 | 104 | |
| 6 | 2003 | 95 | |
| 7 | 2007 | 90 | |
| 8 | 2012 | 89 | |
| 9 | 2009 | 89 | |
| 10 | 1990 | 81 | |
| 11 | 2001 | 69 | |
| 12 | 1995 | 68 | |
| 13 | 1996 | 60 | |
| 14 | Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. | 1998 | 59 |
| 15 | 2006 | 57 | |
| 16 | 2001 | 49 | |
| 17 | 2005 | 42 | |
| 18 | 1991 | 42 | |
| 19 | 2001 | 34 | |
| 20 | 1995 | 33 |
About John Pablo
John Pablo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Neurology, Pharmacology and Endocrine and Autonomic Systems, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (14 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers), Neurological disorders and treatments (3 papers), Alkaloids: synthesis and pharmacology (3 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (781 citations), Neurology (375 citations), Toxicology (81 citations), Biochemistry (163 citations) and Neurology (129 citations). John Pablo has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Deborah C. Mash, William Lee Hearn, Neil Hammerschlag, Yujing Qin, Sandra Anne Banack, Larry E. Brand, Sari Izenwasser, Terence E. Johnson, Spyridon Papapetropoulos and Walter G. Bradley. Their work appears in journals such as Neuroreport, Journal of Neurochemistry, Annals of the New York Academy of Sciences, Gene Expression and Marine Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.